Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 9/20 | 1.00 |
| ▸ | CA5A | P35218 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | GAA | P10253 | 1/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.72 |
| ▸ | CA1 | P00915 | 8/20 | 0.66 |
| ▸ | CA9 | Q16790 | 6/20 | 0.66 |
| ▸ | CA12 | O43570 | 5/20 | 0.66 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.64 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | CA3 | P07451 | 1/20 | 0.62 |
| ▸ | CA4 | P22748 | 1/20 | 0.62 |
| ▸ | CA6 | P23280 | 1/20 | 0.62 |
| ▸ | CA7 | P43166 | 1/20 | 0.62 |
| ▸ | MMP1 | P03956 | 1/20 | 0.62 |
| ▸ | MMP2 | P08253 | 1/20 | 0.62 |
| ▸ | MMP9 | P14780 | 1/20 | 0.62 |
| ▸ | MMP8 | P22894 | 1/20 | 0.62 |
| ▸ | MMP13 | P45452 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31527772 | 1.00 | CA2 (1.00) | CA2CA5AKMT2AGAAHTT | |
| SCHEMBL6400928 | 1.00 | CA2 (1.00) | CA2CA5AKMT2AGAAHTT | |
| Iodide SCHEMBL28547164 | 0.98 | CA2 (0.96) | CA2CA5AKMT2AGAAHTT | |
| Hydrochloric Acid SCHEMBL27515852 | 0.98 | CA2 (0.96) | CA2CA5AKMT2AGAAHTT | |
| SCHEMBL17647048 | 0.98 | CA2 (0.96) | CA2CA5AKMT2AGAAHTT | |
| Bromide SCHEMBL25252561 | 0.98 | CA2 (0.96) | CA2CA5AKMT2AGAAHTT | |
| SCHEMBL28485485 | 0.92 | CA2 (0.84) | CA2CA5AKMT2AGAAHTT | |
| SCHEMBL29431934 | 0.92 | CA2 (0.84) | CA2CA5AKMT2AGAAHTT | |
| Alcohol SCHEMBL6121614 | 0.90 | CA2 (0.81) | CA2CA5AKMT2AGAAHTT | |
| SCHEMBL28106126 | 0.86 | VCAM1 (0.77) | CA2CA5AKMT2AGAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 778 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114614058-B | Thin-layer composite proton exchange membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-115637149-B | Perovskite quantum dot diffusion plate and preparation method thereof | 无锡极电光能科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-114308121-B | Phosphine oxide catalyst and preparation method and application thereof | 浙江工业大学 | 2024-02-23 | — | — | CN | claimed |
| CN-115521783-B | Method for passivating perovskite quantum dot surface defects | 无锡极电光能科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-108947931-B | Thiazole amide compound, preparation method thereof, pharmaceutical composition and application | 中国科学院上海有机化学研究所 | 2023-07-07 | — | — | CN | claimed |
| CN-115637149-A | Perovskite quantum dot diffusion plate and preparation method thereof | 无锡极电光能科技有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-115521783-A | Method for passivating surface defects of perovskite quantum dots | 无锡极电光能科技有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-114614058-A | Thin-layer composite proton exchange membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-06-10 | — | — | CN | claimed |
| CN-114432903-A | Composite membrane with acid resistance and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-114308121-A | Phosphine oxide catalyst and preparation method and application thereof | 浙江工业大学 | 2022-04-12 | — | — | CN | claimed |
| US-20080200454-A1 | CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. | 2008-08-21 | — | — | US | claimed |
| EP-1931645-A2 | N- (3-AMINO-QUINOXALIN-2-YL) -SULFONAMIDE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | Exelixis, Inc. (US) | 2008-06-18 | — | — | EP | claimed |
| CN-101048383-A | Gonadotropin releasing hormone receptor antagonists | WYETH CORP (US) | 2007-10-03 | — | — | CN | claimed |
| WO-2007108742-A1 | NOVEL TETRALINS AS 5-HT6 MODULATORS | ASTRAZENECA AB (SE) | 2007-09-27 | — | — | WO | claimed |
| WO-2007044729-A2 | N- (3-AMINO-QUINOXALIN-2-YL) -SULFONAMIDE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | EXELIXIS, INC. (US) | 2007-04-19 | — | — | WO | claimed |
| US-6337368-B1 | WATER INSOLUBLE CARRIERS WITH P-NITROBENZOIC ACID, AROMATIC AMINES, AMIDES, SULFONAMIDES AND HYDRAZIDES | KANEKA CORPORATION (JP) | 2002-01-08 | — | — | US | claimed |
| CN-1247537-A | Sulfonamide compounds having 5-HT receptor activity | KNOLL AG (DE) | 2000-03-15 | — | — | CN | claimed |
| EP-0117080-B1 | SKIN TREATMENT COMPOSITION | UNILEVER PLC (GB) | 1992-04-08 | — | — | EP | claimed |
| EP-0270293-A1 | Substituted 3-nitrobenzenesulfonamides useful as adjuncts in radiation therapy | MERCK & CO. INC. (US) | 1988-06-08 | — | — | EP | claimed |
| EP-0117080-A2 | Skin treatment composition | UNILEVER PLC (GB) | 1984-08-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200454-A1 | CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | CTSS, CTSK, CTSZ | CA2 413/4885CA5A 2019/4885KMT2A 4390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.